System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print

PubMed: 42584078 DOI: 10.1093/rheumatology/keag411

Attainment of early targets does not ensure a complete response at 12 months in lupus nephritis, especially in nephrotic-range proteinuria.

Rheumatology (Oxford)

Authors: Maria Pappa, Konstantinos Drougkas, Antigone Pieta, Maria Kosmetatou, Spyridon Katechis, Myrto Nikoloudaki, Nektarios-Marios Liapis, Christina Tsalapaki, Evangelia Argyriou, Theodoros Dimitroulas, Myrto Cheila, Charalampos Papagoras, Andreas V Goules, Christina Katsiari, Dimitrios Vassilopoulos, Paraskevi V Voulgari, Dimitrios Boumpas, Maria G Tektonidou, George K Bertsias, Antonis Fanouriakis

Affiliations

  • Rheumatology and Clinical Immunology Unit, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
  • Rheumatology and Clinical Immunology, University of Crete, Medical School and University Hospital of Iraklio, Iraklio, Greece.
  • Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, Larissa, Greece.
  • Clinical Immunology- Rheumatology Unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens, General Hospital of Athens Hippokration, Athens, Greece.
  • Rheumatology Unit, Sismanogleio General Hospital of Athens, Athens, Greece.
  • Fourth Department of Internal Medicine, Hippokration University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Rheumatology Clinic, Evangelismos General Hospital of Athens, Athens, Greece.
  • First Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Department of Pathophysiology, National and Kapodistrian University of Athens, Athens.

Abstract

OBJECTIVE

EULAR recommends early proteinuria reduction targets in lupus nephritis (LN) (≥25% at 3 months and ≥50% at 6 months). We examined the predictive value of these targets for achieving complete renal response (CRR) at 12 months, a surrogate for favorable long-term outcomes.

METHODS

We examined data from a cohort study of patients with biopsy-proven LN. Regression models were applied to identify independent associations with 12-month CRR. Performance metrics for EULAR 3- and 6-month targets were calculated for the whole cohort, and for patients with nephrotic or subnephrotic baseline proteinuria.

RESULTS

132 patients with biopsy-proven LN were included; 92 (69.7%) achieved CRR at 12 months. Attainment of EULAR-proposed 3- and 6-month targets was independently associated with 12-month CRR (OR 7.38, 95% CI 2.84-20.4 at 3 months; OR 10.6, 95% CI 3.74-32.4 at 6 months). Higher baseline proteinuria levels were inversely associated with CRR in both models (OR 0.77 and 0.75 per 1 g increase, respectively). Both targets had high sensitivity (86-89%) but moderate specificity (40-45%), while negative likelihood ratios (0.27-0.31) suggested that failure to achieve these early targets meaningfully reduced the probability of subsequent 12-month CRR. In patients with nephrotic range proteinuria, both targets showed lower specificity (0.30 and 0.17), suggesting limited ability to predict 12-month CRR.

CONCLUSIONS

Failure to achieve the EULAR 3- and 6-month proteinuria targets serves as a warning sign for suboptimal response at 12 months. In patients with baseline nephrotic range proteinuria attainment of early response has limited predictive value for 12-month CRR.

MeSH

Proteinuria, Lupus Nephritis, Predictive Value Of Tests, Biopsy, Rheumatic Diseases, Nephritis